Priti Patel's Insider Trades & SAST Disclosures
Priti Patel's most recent trade in National Vision Holdings Inc was a trade of 24,672 Restricted Stock Units done . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Priti Patel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| National Vision Holdings Inc | Priti Patel | General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 24,672 | 35,890 | - | - | Restricted Stock Units | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 3,363 | 14,556 | - | - | Restricted Stock Units | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 3,363 | 12,321 (0%) | 0% | - | Common Stock | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,988 | 11,218 | - | - | Restricted Stock Units | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,988 | 14,133 (0%) | 0% | - | Common Stock | |
| National Vision Holdings Inc | Priti Patel | General Manager | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.71 per share. | 01 Mar 2025 | 1,382 | 10,939 (0%) | 0% | 12.7 | 17,565 | Common Stock |
| National Vision Holdings Inc | Priti Patel | General Manager | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.66 per share. | 01 Mar 2025 | 1,228 | 12,905 (0%) | 0% | 12.7 | 15,546 | Common Stock |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 350 | 14,206 | - | - | Restricted Stock Units | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 350 | 11,289 (0%) | 0% | - | Common Stock | |
| National Vision Holdings Inc | Priti Patel | General Manager | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.71 per share. | 01 Mar 2025 | 144 | 11,145 (0%) | 0% | 12.7 | 1,830 | Common Stock |
| Neoleukin Therapeutics Inc | Priti Patel | Former Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 10,000 | 0 | - | - | Restricted Stock Units | |
| Neoleukin Therapeutics Inc | Priti Patel | Former Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 10,000 | 41,082 (0%) | 0% | 0 | Common Stock | |
| Neoleukin Therapeutics Inc | Priti Patel | Former Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.69 per share. | 31 Mar 2023 | 3,769 | 37,313 (0%) | 0% | 0.7 | 2,608 | Common Stock |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 35,000 | 35,000 | - | - | Restricted Stock Units | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 35,000 | 45,462 (0%) | 0% | 0 | Common Stock | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.60 per share. | 01 Feb 2023 | 14,380 | 31,082 (0%) | 0% | 0.6 | 8,588 | Common Stock |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 10,000 | 12,000 (0%) | 0% | 0 | Common Stock | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.22 per share. | 30 Apr 2022 | 5,538 | 6,462 (0%) | 0% | 1.2 | 6,749 | Common Stock |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 70,000 | 70,000 | - | - | Restricted Stock Units | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 475,000 | 475,000 | - | - | Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 20,000 | 20,000 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges